4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001144204-18-029352
Chief Financial Officer sold 12,400 shares at $9.00 ($111,600)
- Chief Financial Officer acquired 12,400 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BLOCH KATHLEEN P. · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-05-16 | Exercise or conversion : show line 1 in the form | +12,400 | $4.69 | $58,156 | 265,704 | D |
| 2018-05-16 | Sale : show line 2 in the form | −12,400 | $9.00 | $111,600 | 253,304 | D |
| Open-market sales · 12,400 sh · avg $9.00 · $111,600 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-05-16 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −12,400 | 0 | D |
Loading xslF345X03/tv494430_4.xml…